introduction in medical genetics 6 - reprodukčna genetika
TRANSCRIPT
RNDr. I. Černáková, PhD.
Introduction in medical genetics 6
Slovenská zdravotnícka univerzita, Bratislava, 27.3.2017
Link between genetics and infertility disorders
• 1940s – gynecomastia, aspermatogenesis and increased secretion of FSH (Harry Klinefelter) – Klinefelter syndrome
• 1956 – determination of karyotype in KS patients: 47,XXY
• 1938 – the first description of Turner syndrome by Henry Turner
• 1964 – karyotype 45,X determination in patient with Turner syndrome
3 000 – 5 000 genes directly or indirectly influencing human fertility:
- genes expressed just in germ cells
- genes expressed just or also in gonads
- genes expressed in ontogenesis
Laboratory tests available:
- Genetic screening:
- basic panethnic: CF, SMA, hemoglobinopathies
- expanded population specific –Middle Eastern, Askenazi Jewish, Mediterranean
- expanded panethnic - few hunderds of autosomal recessive and X-linked diseases
Link between genetics and infertility disorders
- Genetic diagnosis of monogene disease in the family
- Genetic examination for some infertility-related mutations
(FSHR, Fragile X, FMR I, AR gene)
- Whole genome testing of infertility
(Atypical ovarian response, premature ovarian insufficiency, male factor infertility, disorders of sexual development, recurrent pregnancy loss) polycystic ovarian syndrome,
- Preimplantation genetic diagnosis /screening of chromosomal anomalies
(prevention of genetic diseases)
- Prenatal genetic diagnosis
(managment of delivery, treatment and care about child with genetic disease)
Clinical genetic counseling
Why clinical genetics in IVF treatment of infertility?
Infertile and sterile patients are a source of genetic pathologies - occurence of genetic pathology in infertile patients - occurence of particular genetic disease in family - transmission of genetic disease and infertility to the child by IVF treatment
Laboratory test of: - most offen occuring genetic pathologies in infertility - genetic diseases potentially passing to the next generation (karyotype + genetic-based infertility conditions + genetic screening – CF, SMA, hemoglobinopathies...)
Genetic counseling of: - results of genetic tests - risk of transmission of genetic disease to the next generation - explanation of reproductive option of examined couple - clinical genetic examination and laboratory genetic test of relatives at risk of diagnosed disease
Chromosomal abnormalities Preimplantation
period
Implantation I. trimester
II. trimester
III. trimester Term
Inherited birth defects
Early miscarriage 50 to 60 % when gross structural abn. is present
Late miscarriage 12 % 15% 0,5 % 4 – 5 %
50% loss before implantation at 5 to 6 days postconception
Spontanneous miscarriages - 15% of clinically recognized pregnancies before 12th weeks ´gestation
The frequency of chromosomal abnormalities after birth
General population 1 : 200 0,5 %
Infertile couples (spontaneous miscarriages, stillbirths)
1 : 48 2 %
Sterile couples 1 : 10 10 %
Prenatal/Postnatal
genetic diagnostics
Preimplantation
genetic diagnostics
and PGS + Mitoscore
Genet. dg PB Genet. dg of sperm
ET of good embryos
8 cell stage
Infertility treatment
- Endometrial receptivity assay
Zygota ET
REPRODUCTION
OF COUPLE
GENETIC EXAMINATION OF INFERTILE COUPLE
Embryo biopsy –
Day 3 or Day 5
Genetic examination of couple:
- Karyotype - Genetic tests of infertility
- Cystic fibrosis - Carrier genetic test
- Trombophilia mutations - Pharmacogenetics in infertility treatment
- Y-chromosome microdeletion
Genet. dg of spont. miscarriage
The reasons of male infertility
Frequency of infertility world-wide 15 – 20%
Gynecological reasons 40 %
Andrological reasons 40 %
Idiopathic infertility 20 %
WHO GUIDELINES AND
DEVELOPMENT OF SPERM QUANTITY
0
10
20
30
40
50
60
70
80
90
1951 1964 1987 2023
2010
15 mil/ml
The reasons of male infertility
Endogenneous factors
Disorders of sperm production
Disorders of seminal ductus
Genetic factors (translocations, numerical chromosomal abnormalities, Y-deletions, CFTR
gene mutations and mutations in other genes)
Other (anatomical, hormonal, age of man ...)
Hominid ancestry
Exogenneous factors
Industrial exhalation
Chemicals – herbicids, pesticids, insecticids
X-ray, microwave, mobil cells
Industry – heavy metals
Life style factors – smoking, alcohol, drugs, obesity, sauna/thermal baths
Inflammation diseases, radio-/chemotherapy
Human male germ cells
Characterization:
Poor quality exhibiting frequent morphological defects
Impaired motility
Poor chromatine compaction and condensation
High incidence of DNA fragmentation
Impaired capacity for oocyte recognition and fusion
Major source of of disease-causing mutations in humans
Infertility Dominant single gene disease
Childhood cancer
Birth defects
Immunological disorders
Sperm analysis - basic
(WHO 2010)
Volume > 1,5 ml
Count > 15 mil/ml
Motility > 40 %
Progressive motility > 32 %
Morphology > 4% of normal sperm
pH ≥ 7,2
Liquification up to 30 min
Leucocytes < 1 mil/ml Leu
Sperm cell disorders
Paternal imprinting disorders
Chromosomal aneupoidy
Defects of morphology
Defects of vitality (mitochondria insufficiency)
Residual cytoplasma
Protamines insufficiency
VitalSperm Vitality examination – Progressive vitality < 40%
Living immotile sperm Dead sperm - necrozoospermia
Pathological finding
of epididymis
Structural defects of tail
+
Defects/lower count of mitochondria
Urological, sperm donation DNA fragmentation
Antioxidants + ICSI
LeucoTest
Examination
of leucocytes in ejaculate
Small round cells
> 1 mil/ml
Epitelial cells Leu > 1 mil/ml
Urological examination
Why is important to do correct semen analysis?
To know correct diagnosis of male infertility
To suggest and realize additional genetic tests
To propose to the couple their real opportunities to have baby
To choose the appropriate method of ART
(IVF/ICSI, PICSI, MACS or TESE)
or to decise for a sperm donation
ProtamineSperm
Examination of presence of protamines in sperm nucleus
– Morphology < 4%
– Idiopatic infertility
Protamine test When the strands are not packed well –
long DNA strands succeptible to damage
Sperm DNA fragmentation
Low probability of fertilization of oocytes
Infertility
Counselling of couple, IVF / ICSI treatment
Oxidative stress
Production of DNA adducts
DNA endonukleases cleavage
Imprinting disorders
DNA damage and
mutations
Assisted reproduction
Thermal stress in scrotum
DNA Reparation normal
Normal
embryogenesis
Abnormal development of
embryos
Unsuccessful implantation
Spontanneous miscarriages
Single gene disease in
children
Children tumor diseases abnormal
Infection
Disorders of spermatogenetis:
- residual of cytoplasma
- abortive apoptosis
- abnormal protamination
Disorders of DNA replication
increased by age
Xenobiotics:
- life style
- medications and oncotherapy
- professional environment
FragmentSperm
Direct examination of DNA damage
-ssDNA a dsDNA –
by TUNEL method
(fluorescence microscopy)
INDEPENDENT PROGNOSTIC
FACTOR for measurement
of sperm quality relating to the
MALE INFERTILIY
Sperm DNA fragmentation
Up to 15 % - normal level
> 15 % - IUI
> 20 % - IVF/ICSI
> 30 % - small probability of
spontaneous pregnancy
Men with OAT + Men with normal SPG
idiopatic infertility (normal SPG)
repeated unsuccessful IVF cycles: non-fertilized oocytes
no cleveage of embryos
embryo fragmentation
no clinical pregnancy
spontanneous miscarriages
men older than 40 years
exposition of toxins/medications
smoking
infections, inflammation
Sperm donation – testing of donors
INDICATIONS – Sperm DNA fragmentation
AneuSperm
FISH examination of sperm karyotype – chromosomal
aneuploidy
Examination of aneuploidy level
in sperm sample
- chromosomes 13, 18, 21, X a Y
Men with
sperm aneuploidy
Infertile male patients with sperm
of pregnancy is miscarried by couples
with normal aneuploidy rate in sperm 60%
Embryos: aneuploidy in embryos
triploidy in embryos
Pregnancy: decreased pregnancy rate of the treatment of infertility
increased frequency of spontaneous miscarriages
Births: increased risk of aneuploidy in baby
Identification of men with low reproductive success
Personalized genetic counseling of infertile couple in relation to IVF treatment
Preimplantation genetic screening of aneuploidy – goals:
- to increase the pregnancy rate
- to decrease the risk of spontaneous miscarriage
- for a higher chance to have healthy baby
Sperm aneuploidy effects
Impact of sperm aneuploidy on pregnancy rate/ET
in IVF treatment and the incidence of spontaneous miscarriages
Men with OAT + Men with normal SPG
Repeated unsuccessful IVF cycles: non-fertilized oocytes
no cleavage of embryos
embryo fragmentation
no clinical pregnancy
Repeated spontanneous miscarriages with normal karyotype of couple
Chemicals /Medication exposition /Chemotherapy/Radiotherapy
Preimplantation genetic diagnostics
Donation programme
The indications - AneuSperm
Why to do the comprehensive sperm analysis?
• To know the correct diagnosis of male infertility
• To suggest the additional tests for correct diagnosis (karyotype, CF mutation screening, Y-chromosome deletions, FSH gene and FSH receptor gene polymorphism for hormonal treatment ...)
• To explain possible causes of infertility and the risk of transmission of infertility, recurrent miscarriages and genetic diseases to their children
• To guide the treatment of male infertility: - antioxidants - hormonal treatment by low dose-long term FSH according to the genotype - to recommend the appropriate methods of IVF: ICSI, TESE for non-obstructive azoospermia, MACS / PICSI preimplantation genetic screening for aneuploidy, for CF ....)
Why clinical genetics in IVF treatment of infertility?
Infertile and sterile patients is s source of genetic pathologies - occurence of particular genetic disease in family - occurence of genetic pathology in infertile patient - transmission of genetic disease and infertility to the child by IVF treatment
Laboratory test of: - most offen occuring genetic pathologies in infertility - genetic diseases potentially passing to the next generation (karyotype + genetic-based infertility conditions + genetic screening – CF, SMA, hemoglobinopathies...)
Genetic counseling of: - results of genetic tests - risk of passing of genetic disease to the next generation - explanation of reproductive option of examined couple - clinical genetic examination and laboratory genetic test of relatives at risk of
diagnosed disease
CLINICAL GENETICIST - Genealogy, physical examination,
genetic counseling
- Karyotype
- Cystic fibrosis
- Trombophilic mutations
- Y-chromosome microdeletion
- examination of genetic diseases occuring in some population
(thalassemias, familial mediterrean fewer, Jewish specific disorders,
or in particular patients/family (monogene diseases)
Foresta C, Ferlin A, Gianaroli L, Dallapiccola B:
Guidelines for the appropriate use of genetic tests in infertile couples.
Eur J Hum Genet, 2002, 10, 5, 303 – 312.
Preconception clinical genetic service of infertile couples
Chromosomal abnormalities and human reproduction
Disturbance of gametogenesis
- male infertility: oligoasthenoteratozoospermia
azoospermia
- female infertility: disturbance of menstrual cycle
premature ovarian insufficience
Unbalanced chromosome abnormalities in gametes
- reproduction failures : spontaneous miscarriages
stillbirths
birth defects
neonatal death
Medical indications of cytogenetic examination of infertile couple
1. Occurence of chromosomal abnormality in family
2. Congenital abnormality in development and/or mental disabbility in family
3. Infertility (minimal 2 spont. miscarriages, stillbirths, repeated implantation failures in IVF cycles)
4. Idiopathic infertility (more than 1 year or 6 months when woman is older than 35 yrs.)
5. Andrologic infertility (OAT, azoospermia)
6. Disorders of menstrual cycle (amenorhea, oligomenorhea)
7. Anatomical defects of male/female genitalia
8. Professional and medical exposition
9. Couples before PGS of aneuploidy
Cystic fibrosis
Indication of examination of CFTR gene mutation
Male infertility - oligozoospermia ( 1< 106/ml )
- azoospermia
Men with congenital bilateral absence of vas deference (CBAVD)
Familial occurence of cystic fibrosis - based on genealogy
Indications of examination - Trombophilic mutations
Leiden mutation (Factor V gene) Protrombin gene mutation (Factor II)
- Deep venal trombosis in personal and/or familial history
- Repeated spontaneous miscarriages
- Repeated unsuccessful IVF cycles
- Reproductive history:
stillbirth, premature delivery, abruption of placenta, preeclampsia, IUGR
Y-chromosome microdeletions
Men with severe oligozoospermia or azoospermia and Y-chromosome microdeletion:
- 100% of probability of microdeletion
and infertility transmission to the sons
- Decreased fertilization rate of oocytes
- Less quality of embryos
Indication of examination:
- Oligozoospermia (1<106/ml) – 5% of men
- Azoospermia – 10% of men
Genetic counseling of result of test and explanation
of reproductive option and IVF treatment (TESE/MESA)
Genetic laboratory tests
- couples with repeated spontaneous miscarriages
Test Who? Material
Karyotype Both partners Peripheral blood
Annexin Both partners
Peripheral bloos / buccal cells
Trombophilia mutations FV, FII
Woman Peripheral bloos / buccal cells
Sperm DNA fragmentation + ROS
Men Sperm
Sperm chromosome aneuploidy
Men Sperm
+ Clinical genetic counseling
Annexin 5
ANXA5 gene – chromosome 4q27 4 polymorphisms in promotor of the gene: 19G>A (rs112782763) +1A>C (rs28717001) 27T>C (rs28651243) 76G>A (rs113588187)
M2 haplotype M1 haplotype
N (WT) – standard alllele M1 haplyotype – non-pathologic, no complications in pregnancy, no increased risk of spontaneous miscarriage M2 haplotyp – defect of placental vasculature, venal tromboembolism, 4x increased risk of spontaneous miscarriage, IUGR and intrauterine death of fetus, gestational hytertension, preeklampsia M2/M2 haplotype of fetus – severe form of IUGR
Annexin 5
Activity of ANXA5 gene promoter variants in luciferase reporter gene assays.
Nadia Bogdanova et al. Hum. Mol. Genet. 2007;16:573-578
© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected]
Genotypes: N/N N/M1 M1/M1 N/M2 alebo M1/M2 M2/M2 Incidence: of IVF patients has M2 haplotype of persons has M2/M2
The fetus has an increased risk to inherit minimal one M2 maternal or paternal
Men has no risk himself, nor woman when is not pregnant!
44%
6%
• Idiopathic infertility – 37% • Repeated miscarriages • OAT - 40% • PCOS – 35% • Premature ovarian insufficiency
Annexin 5
The treatment – low molecular weight of heparine NO ASPIRIN!
from embryo transfer – to end of puerperium
Which material to examine? • Peripheral blood • Buccal cells
How? • Genetic test • NO IMMUNOLOGIC !
PGD / PGS Preimplantation genetic diagnostics - analysis of genetic disorders in early human embryos before their embryotransfer in uterus as a prevention of single gene disorders
• Introduced in routine: 1990 – adrenoleukodystrophy
Preimplantation genetic diagnostics – prevention of genetic disorder
transmission to the next generation
- single gene disorders - chromosomal translocations
Preimplantation genetic screening af aneploidy – prevention of transfer of
chromosomally abnormal embryos of „poor responder“ couples
- older women (35+)
- repeated unsuccessful impalntation of embryos
- repeated spontaneous miscarrages
- male infertility
PGD medical indications
Preimplantation genetic diagnosis
- Diagnostics of single gene disorders
- Diagnostics of translocations
- Diagnostics of late-onset genetic diseases or cancer diseases occuring
in adulthood
- HLA typization of embryos
- Mitochondrial diseases
PGD - steps
Haplotype analysis of family
– PGD set-up
IVF/ICSI
Hormonal stimulation
Oocyte pick-up
Fertilization
Embryo biopsy – Day 3,
Day 5 or blastocentesis
Genetic analysis
IVF – Embryo transfer
Vyšetrovaný materiál
1st polar body 2nd polar body
Trophectoderm of blastocyst – Day 5 Blastomere - Day 3
Embryo biopsy
PCR – PGD steps
A. Biopted of cell (cells) is transfered
in lysis buffer solution in eppendorf
tube
B. Its genome is released from nucleus
of cell.
C. Whole genome amplification (WGA)
– amplification of all genome of cell
D. Fragmentation analysis of examined
gene using capillary electrophoresis
– analysis of genotype of embryo
Haplotype analysis
Allelic drop-out risk
Analysis of 5 fully informative DNA
markers linked to the mutation
Haplotype analysis of the family
Marker –IVS10CA
proband - sick
mother
father
healthy daughter
IVS10CA Alela 1 Alela 2
Proband - sick 318 330
Mother 320 330
Father 318 320
Healthy daughter 320 320
Analysed
12 DNA markers
before, inside and
after CFTR gene
PGS medical indications
Preimplantation genetic screening of aneuploidy
FISH: 8 chromosomes
aCGH / NGS: all chromosomes
- Women older than 35 - 37 years
- Repeated unsuccessfull IVF cycles
- Repeated spontaneous miscarriages
- Trisomic fetus in previous pregnancy (Down syndrome)
- Male infertility (OAT gravis, TESE/MESA)
0,001,002,003,004,005,006,007,008,009,0010,0011,0012,0013,0014,0015,00
16 X 212215 131814 9 2 4 7 8 2010 1217 6 5 11 3 19 Y
Chromozóm
Pe
rce
nto
%
Frequency of chromosomal abnormalities
in spontaneously miscarriages – Ist trimester
Frequency of aneuploiy in preimplanattion period – abnormalities detected by CGH method
Munné et al. , 2010
PGD/PGS schematic representation Day 0 Oocyte pick-up
Day 1 Fertilisation
Day 3 Biopsy of blastomere
Day 3 + Day 4 results, report FISH, aCGH, PCR-PGD
Day 5 Embryo transfer Biopsy of vitrification of biopted embryos trophoectoderm aCGH, NGS ET in next menstrual cycle
Spontaneous miscarriages I. Aneuploidy
Natural conception: 15 %
ART: 23 – 37 %
PGS: 12 - 15 %
2 x comparing to ICSI
Spontaneous miscarriages II. Translocations
Spontaneous miscarriages:
Natural conception 87 %
PGD 18 %
5 x
Take-home-baby rate:
Natural conception: 11,5 %
PGD: 81,4 %
7 x
Trisomy child delivery
Natural conception:
2,6 % trisomy 13, 18 a 21 (chorionic villi examinations)
PGD cycle:
0,6 % trisomy 13, 18 a 21
independent on type of hormonal stimulation
4 x
Mitochondria during embryogenesis
Mitoskóre Implantation rate %
< 18 81%
18-24 50%
24-50 65%
> 50 18%
> 160 none
Importance of PGD / PGS
Diagnosis - diagnosis of chromosomal anomaly/single gene disease according to the patient´s medical indication
Prevention - decreased risk of spontaneous miscarriage in IVF couples to 15%
PREVENTION OF DELIVERY OF CHILD WITH GENETIC DISORDER !
Treatment - higher effectivity of infertility treatment in poor prognosis patients
Prognosis - prognosis & change of infertility treatment in next IVF cycle
Finance - next examinations & IVF treatment
Psychology - psychic status of infertile couple
Single gene disorders
• Fenotyp effects are caused by the mutation in one gene
• Mendelian type of inheritance
• 7 000 single gene disorders
WHO: Prevalence 10 : 1000
20% of cases of child mortality
in developed countries
40% of medical interventions
in children hospitals
(Kanada – Scriver, 1995)
Carrier screening of single gene diseases
single gene diseases AR a X-linked inheritance
General population – affected 1 : 100
Carriers
Cystic fibrosis 1 : 25 4 %
Spinal muscular atrophy 1 : 50 2 %
Αlpha-/Beta-hemoglobinopathy 1 : 48 2 %
- analysis of 549 genes, 600 single gene diseases using NGS
- high risk of transmission of disease with recessive inheritance
(AD or X-linked) to the next generation
2.1 pathogenic mutation/person
7.1 % of tested persons don´t have pathogenic mutation
8% couples carry the mutation in the same gene
( so called „genetic incompatibility“)
Carrier screening of single gene diseases
Preimplantation genetic diagnostics
1 : 100 1 : 100 000
Risk of the delivery of the child affected by single gene disorder
For whom? Before natural conception
Before assisted conception
Oocytebanking and spermbanking
Carrier screening of single gene diseases
Single gene disorders can´t be cured, but they can be prevented
Primary prevention of occurence of single gene disorders in family
- Preimplantation genetic diagnostics
- Carrier screening of single gene disorders
Genetics and IVF clinic a multidiscipline dialogue in assisted reproduction
Clinical geneticist
- physical examination
- genealogy
- pre-test counseling
- indication of genet. lab. tests
- post-test counseling
IVF clinic
Genetic lab
- Molecular cytogenetics
Genetic lab
- DNA lab
Genetic lab
- Cytogenetics
Urology
Gynecology
Genetic lab
- PGD lab
Endocrinology
Bring genetics in your practice
TREATMENT
GUIDE treatment, such as gonadotropin dosage and prescription of blood thinners
MANAGE treatment risks, such as ovarian hyperstimulation syndrome
DECISION-MAKING
INFORM decisions about reproductive options, plan and treatment protocol
RECOMMEND preimplantation genetic diagnosis/screening (PGD/PGS)
GUIDANCE
PREDICT and prepare patients for possible outcomes of infertility treatment
EXPLAIN possible causes of infertility or recurrent miscarriage
Thank you for your attention
Genetic lab ReproGen
Bratislava, Slovakia
Tel: 0948 230 661
www.reprogen.sk